AzTrials
AzTrials

IatrogenesisCORRESPAGENCT05936515

Evaluation of the Impact of a Paramedical Training Program for Nurses and Nursing Assistants on the Length of Stay and Prevention of Hospital Iatrogenic Complications in Elderly Patients

An observational study of Iatrogenesis, run by Hospices Civils de Lyon at 5 sites in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

In France, hospitalised elderly patients (EP) aged >75 years are expected to represent 1/3 of patients by 2030 (22% in 2015). In acute care wards outside geriatrics, the average length of stay increases with age, i.e. 8.5 days after the age of 90 compared with 5.5 days for younger patients. Read more about this study

Who is it for?
Ages 75 years and older
Conditions the study is for
Iatrogenesis
What is being tested?
Training of nurses and nursing assistants
How many people
2,671 participants
Where
5 sitesFrance
Study dates
1 May 2023to 1 Jul 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 75 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Study population: This study covers patients aged 75 and over hospitalised in participating specialitist wards (excluding geriatrics) (medicine, rheumatology, neurology, pneumology, orthopaedic surgery, digestive surgery, ENT and facial surgery)

Who may be able to join

  • Patients aged 75 years and over hospitalised in a participating specialtist wards
  • not objecting to the study,
  • including those under guardianship or curatorship.

Who cannot join

  • Patient not affiliated to a social security scheme
  • Patient at the end of life

Trial locations and contacts

5 sites in 1 country. Contact the study team or a site near you to ask about taking part.

5 sites in 1 country

France5 sites, 5 recruiting
  • Centre Hospitalier de Bourg en Bresse

    Bourg-en-Bresse, 01012

    Christophe VAITON, cvaiton@ch-bourg01.fr

    Recruiting
  • Croix Rousse Hospital

    Lyon, 69004

    Recruiting
  • CH Annecy Genevois

    Metz-Tessy, 74370

    DUSSEL Anne Sophie, MD, addussel@ch-annecygenevois.fr

    Not yet recruiting
  • service de court séjour gériatrique, Hôpital Lyon Sud

    Pierre-Bénite, 69495

    Thomas GILBERT, MD, thomas.gilbert@chu-lyon.fr

    Recruiting
  • Hôpital Nord-Ouest

    Villefranche-sur-Saône

    Frederique COSTA PATRY, MD, fcostapatry@hno.fr

    Not yet recruiting

Other trials in France

About this study

In France, hospitalised elderly patients (EP) aged >75 years are expected to represent 1/3 of patients by 2030 (22% in 2015). In acute care wards outside geriatrics, the average length of stay increases with age, i.e. 8.5 days after the age of 90 compared with 5.5 days for younger patients. Dependence related to hospitalisation, partly avoidable, occurs in 30 to 60% of patients aged over 70. Faced with this situation Geriatric Mobile Teams (GMT) were created in 2002 to meet the need for geriatric expertise in hospitals and in the community by making punctual evaluations. Expert and multidisciplinary, the GMTs are a referring team for "advice, information and training for health care teams" for the care of vulnerable EPs. The GMTs are dependent on an exclusively medical demand system. The lack of knowledge of a specific care for EPs by nurses and nursing assistants and the occasional contribution of GMTs prevents a systematic targeted a for EP. Over the past 30 years, an American nursing programme (NICHE) aimed at improving the overall care of EPs in hospitals has shown that the training of geriatric resource nurses in speciality wards brought about a significant change in hospital geriatric culture. The training is based on evidence based practice including the HELP programme targeting confusion. The HELP programme has shown that nurses and nursing assistants play a pivotal role in reducing the incidence of hospital confusion. In the USA, the implementation of NICHE begins with the creation of a team of nursing leaders (geriatric/education/clinical care experts), dedicated to the coordination of the training and the companionship of geriatric resource nurses. Within the framework of the targets of the Ségur de la santé 2020 and Ma Santé 2022, our hypothesis is that an adaptation of NICHE to the French health context could improve specific care for EP in specialist wards, reduce the occurrence of complications and reduce the length of stay. Indeed, the GMT would ensure this coordination role in the training and support of a nurse and nursing assistant duo, based on the model of hygiene correspondents, in order to disseminate good geriatric practices.

Conditions
Iatrogenesis
Being tested
Training of nurses and nursing assistants
Keywords
Care of the elderly, training of paramedical duo, specialtist wards, geriatric resource nurse

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Training of nurses and nursing assistantsOther

    Training of nurses and nursing assistants, based on the model of hygiene correspondents, in order to disseminate good geriatric practices

Study groups in NCT05936515
Study groupRoleWhat they receive
Post-intervention group (Training course group)The experimental group will be composed of patients aged 75 and over hospitalised in specialised departments after the establishment of geriatric correspondents trained in the specific care for the elderly.
Receives: Other: Training of nurses and nursing assistants
Pre-intervention group (Control group)The control group will be composed of patients aged 75 years and over hospitalised in specialised departments before the introduction of geriatric correspondents trained in the specific care for the elderly. Their care will be conducted in accordance with usual practices.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Length of stay

    Length of stay compared between groups according to whether or not geriatric correspondents are in place. This criterion has the advantage of being easy to measure, robust and a reflection of overall care. It depends on the occurrence of complications that can be prevented by the intervention of paramedical staff.

    Measured: The length of stay is calculated as the number of days between admission to the inclusion service and discharge documented in the medical record, assessed up to one month.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jul 2023
  2. Study start1 May 2023
  3. Primary completion1 Jul 2027 (estimated)
  4. Study completion1 Jul 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Retrospective
Enrolment
2,671 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05936515
Sponsor's protocol ID
22-5125
Acronym
CORRESPAGE
Status last verified
Jun 2023
First submitted
22 Jun 2023
Last updated
7 Jul 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Iatrogenesis, run by Hospices Civils de Lyon at 5 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 7 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Eleonore BROCARD, MD (00 33 4 72 11 95 61, eleonore.brocard@chu-lyon.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Length of stay (time frame: The length of stay is calculated as the number of days between admission to the inclusion service and discharge documented in the medical record, assessed up to one month.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jul 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in